Crossmark

The prognostic role of baseline 18F-FDG PET/CT SUVmax and SUVmax change in patients with node-positive breast cancer receiving neoadjuvant chemotherapy

Crossref DOI link: https://doi.org/10.1016/j.remnie.2021.04.003

Published Print: 2022-01

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Can, Canan

Akdeniz, Nadiye

Kömek, Halil

Gündoğan, Cihan

Urakçı, Zuhat

Işıkdoğan, Abdurrahman
License Information

Text and Data Mining valid from 2022-01-01
More Information

This article is maintained by: Elsevier

Article Title: The prognostic role of baseline 18F-FDG PET/CT SUVmax and SUVmax change in patients with node-positive breast cancer receiving neoadjuvant chemotherapy

Journal Title: Revista Española de Medicina Nuclear e Imagen Molecular (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.remnie.2021.04.003

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.remn.2021.02.010

Content Type: article

Copyright: © 2021 Sociedad Española de Medicina Nuclear e Imagen Molecular. Published by Elsevier España, S.L.U. All rights reserved.

Document is current

Any future updates will be listed below